TDP-43 controls lysosomal pathways thereby determining its own clearance and cytotoxicity

Human Molecular Genetics
Christine LeibigerRalf J Braun

Abstract

TDP-43 is a nuclear RNA-binding protein whose cytoplasmic accumulation is the pathological hallmark of amyotrophic lateral sclerosis (ALS). For a better understanding of this devastating disorder at the molecular level, it is important to identify cellular pathways involved in the clearance of detrimental TDP-43. Using a yeast model system, we systematically analyzed to which extent TDP-43-triggered cytotoxicity is modulated by conserved lysosomal clearance pathways. We observed that the lysosomal fusion machinery and the endolysosomal pathway, which are crucial for proper lysosomal function, were pivotal for survival of cells exposed to TDP-43. Interestingly, TDP-43 itself interfered with these critical TDP-43 clearance pathways. In contrast, autophagy played a complex role in this process. It contributed to the degradation of TDP-43 in the absence of endolysosomal pathway activity, but its induction also enhanced cell death. Thus, TDP-43 interfered with lysosomal function and its own degradation via lysosomal pathways, and triggered lethal autophagy. We propose that these effects critically contribute to cellular dysfunction in TDP-43 proteinopathies.

References

May 17, 1996·The Journal of Biological Chemistry·V WestphalH B van den Hazel
Oct 5, 2002·The Journal of Biological Chemistry·Chao-Wen WangDaniel J Klionsky
Jan 15, 2005·Biochemical Society Symposium·J Paul LuzioNicholas A Bright
Feb 27, 2008·Biochimica Et Biophysica Acta·Joris WinderickxPiotr Zabrocki
Apr 25, 2008·Proceedings of the National Academy of Sciences of the United States of America·Brian S JohnsonAaron D Gitler
Apr 29, 2010·Nature Reviews. Neuroscience·Vikram Khurana, Susan Lindquist
Jan 18, 2011·Developmental Cell·Ranjit SahuLaura Santambrogio
Aug 5, 2011·Current Opinion in Neurobiology·Sandrine Da Cruz, Don W Cleveland
Sep 29, 2011·Proceedings of the National Academy of Sciences of the United States of America·George K TofarisAlfred L Goldberg
Oct 13, 2011·Nature Reviews. Neurology·Peter M Andersen, Ammar Al-Chalabi
Nov 5, 2011·The Journal of Biological Chemistry·Jayarama Krishnan BoseC-K James Shen
Nov 29, 2011·The Journal of Biological Chemistry·Terry SasserRutilio A Fratti
Aug 31, 2012·Proceedings of the National Academy of Sciences of the United States of America·I-Fang WangChe-Kun James Shen
Oct 30, 2013·FEMS Yeast Research·Mario G MirisolaDina Petranovic
May 16, 2014·The Journal of Biological Chemistry·Friederike HansPhilipp J Kahle
Jun 30, 2014·Nature Chemical Biology·Sami J BarmadaSteven Finkbeiner
Mar 31, 2015·Frontiers in Molecular Neuroscience·Ralf J Braun
Oct 4, 2015·Current Topics in Developmental Biology·Allyson L Anding, Eric H Baehrecke
May 29, 2016·Progress in Neurobiology·Mónica ZufiríaAdolfo López de Munain
Jun 28, 2016·Nature Medicine·Wenzhang WangXinglong Wang
Nov 4, 2016·The EMBO Journal·Benjamin M SchwenkDieter Edbauer
Jun 15, 2017·Frontiers in Molecular Neuroscience·Mauricio BudiniAlfredo Criollo
Jul 18, 2017·Frontiers in Molecular Neuroscience·Andreas AufschnaiterSabrina Büttner
Dec 14, 2017·Nature Communications·Guangbo LiuJ Ross Buchan
Jan 10, 2018·Nature Neuroscience·Ching-Chieh ChouWilfried Rossoll
Jan 23, 2018·Microbial Cell·Didac Carmona-GutierrezFrank Madeo

❮ Previous
Next ❯

Citations

Nov 22, 2019·Journal of Neuropathology and Experimental Neurology·Bert M VerheijenFred W van Leeuwen
Nov 27, 2019·Molecular and Cellular Biology·Guangbo LiuJ Ross Buchan
Nov 15, 2018·Frontiers in Molecular Neuroscience·Sonja E Di Gregorio, Martin L Duennwald
Apr 5, 2018·Frontiers in Neurology·Bert M VerheijenFred W van Leeuwen
Nov 20, 2018·Frontiers in Molecular Neuroscience·Andrea Ruetenik, Antonio Barrientos
Apr 21, 2020·Oxidative Medicine and Cellular Longevity·Annika HöhnRoberta Cascella
Aug 18, 2020·Molecular Neurodegeneration·Terry R Suk, Maxime W C Rousseaux
Sep 21, 2018·Frontiers in Molecular Neuroscience·Sebastian HoferDidac Carmona-Gutierrez
Mar 7, 2019·Frontiers in Molecular Neuroscience·Archana PrasadBasant K Patel
Dec 8, 2020·Frontiers in Cell and Developmental Biology·Shinrye LeeHyung-Jun Kim
Mar 25, 2019·Journal of Molecular Biology·Sei-Kyoung ParkSusan W Liebman
May 1, 2021·Biomedicines·Chantal B Lucini, Ralf J Braun
Jul 3, 2021·International Journal of Molecular Sciences·Han-Jou Chen, Jacqueline C Mitchell
Aug 8, 2021·International Journal of Molecular Sciences·Fiona BrightYazi D Ke

❮ Previous
Next ❯

Related Concepts

Related Feeds

Amyloid Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS) is a progressive nervous system disease associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating genetic alterations in this genetically heterogeneous disorder.

Autophagy & Model Organisms

Autophagy is a cellular process that allows degradation by the lysosome of cytoplasmic components such as proteins or organelles. Here is the latest research on autophagy & model organisms

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS & FTD: TDP-43

TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.